<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00834626</url>
  </required_header>
  <id_info>
    <org_study_id>KH-001</org_study_id>
    <nct_id>NCT00834626</nct_id>
  </id_info>
  <brief_title>Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes</brief_title>
  <acronym>IISG</acronym>
  <official_title>Interventional Study of Effects of Ileal Interposition With Sleeve Gastrectomy for Control of Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kirloskar Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kirloskar Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ileal interposition shifts a segment of ileum proximally to achieve maximal meal stimulated
      Glucagon-Like Peptide-1 secretion and coupled with a limited/complete sleeve gastrectomy
      (depending on the Body Mass Index), for Ghrelin reduction, helps in achieving good glycemic
      control in Type 2 Diabetes patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopically, using 6 ports, the ileum is tarnsected at 30 cms proximal to ileo-caecal
      junction and at 200 cms proximal to Ileo-Caecal junction;this ileal segment of 170 cms is
      interposed into proximal jejunum between 20-50 cms distal to Ligament of Treitz. Endo-GIA
      staplers and hand-sown closure was used for the 3 anastomoses. The mesenteric gaps defects
      were closed with 3/0 prolene sutures. Sleeve gastrectomy was done starting from antrum/body
      upto angle of His with a sizing bougie ranging from size 32--58 Fr.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Having Remission of Type 2 Diabetes</measure>
    <time_frame>One year</time_frame>
    <description>The number of patients who 1 year after surgery, have a normal glycated hemoglobin (HbA1c) less than 6.5% and all medication is stopped</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Not Requiring Insulin</measure>
    <time_frame>1 year</time_frame>
    <description>After this Metabolic surgery, usually no Insulin is required by patient after 1 month, and definitely not after 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Showing Decrease in Requirement of Oral Anti-diabetic Agents</measure>
    <time_frame>one year</time_frame>
    <description>Percentage of participants showing decrease in requirement of oral anti-diabetic agents taken earlier for treatment of Type-2 Diabetes, assessed at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Remission in Hypertension</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of participants achieving remission in hypertension, that is blood pressure less than 130/80 mm Hg without any anti-hypertensive medication</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Surgery group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interventional study of the effects of a novel metabolic procedure of Ileal Interposition with Sleeve Gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ileal Interposition with Sleeve Gastrectomy</intervention_name>
    <description>Transposition of a segment of Ileum proximally coupled with limited /complete sleeve gastrectomy.</description>
    <arm_group_label>Surgery group</arm_group_label>
    <other_name>Laparoscopic Ileal Interposition surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes (as defined by American Diabetes Association criteria)of more than 1
             year duration

          -  Body Mass Index 21 - 55 kg/m^2

          -  Poor glycemic control (HbA1c &gt; 8%) despite maximal use of Oral Hypoglycemic Agents and
             Insulin; or good control(lower HbA1c) but requiring progressively higher drug doses.

          -  Gives Informed Consent for the surgery

          -  Postmeal C peptide &gt; 1.0 ng/mL

          -  Age 25 - 75 years

          -  Stable weight for more than 3 months

        Exclusion Criteria:

          -  Type 1 Diabetes

          -  Postmeal C peptide &lt; 1 ng/mL

          -  Pregnancy

          -  Significant nephropathy requiring dialysis

          -  Coexisting systemic disease

          -  Previous gastric or intestinal resection surgery

          -  Obesity due to organic illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Surendra Ugale, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kirloskar Hospital, Hyderabad</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kirloskar Hospital</name>
      <address>
        <city>Hyderabad</city>
        <state>AP</state>
        <zip>500063</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009 Dec;11(12):785-9. doi: 10.1089/dia.2009.0070.</citation>
    <PMID>20001679</PMID>
  </reference>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2009</study_first_submitted>
  <study_first_submitted_qc>February 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2009</study_first_posted>
  <results_first_submitted>February 3, 2011</results_first_submitted>
  <results_first_submitted_qc>July 27, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 31, 2012</results_first_posted>
  <last_update_submitted>August 30, 2012</last_update_submitted>
  <last_update_submitted_qc>August 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ileal Interposition</keyword>
  <keyword>Sleeve Gastrectomy</keyword>
  <keyword>Type-2 Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment started in Jan 2008, at Kirloskar Hospital. Recruitment completed in May 2010.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Surgery Group</title>
          <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1 Year Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Surgery Group</title>
          <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.233" spread="9.605"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>India</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Not Requiring Insulin</title>
        <description>After this Metabolic surgery, usually no Insulin is required by patient after 1 month, and definitely not after 3 months</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Percentage of Participants Not Requiring Insulin</title>
            <description>Percentage of participants not requiring Insulin assessed at 1 year post-surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Not Requiring Insulin</title>
          <description>After this Metabolic surgery, usually no Insulin is required by patient after 1 month, and definitely not after 3 months</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Showing Decrease in Requirement of Oral Anti-diabetic Agents</title>
        <description>Percentage of participants showing decrease in requirement of oral anti-diabetic agents taken earlier for treatment of Type-2 Diabetes, assessed at one year</description>
        <time_frame>one year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgery Group</title>
            <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Showing Decrease in Requirement of Oral Anti-diabetic Agents</title>
          <description>Percentage of participants showing decrease in requirement of oral anti-diabetic agents taken earlier for treatment of Type-2 Diabetes, assessed at one year</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Having Remission of Type 2 Diabetes</title>
        <description>The number of patients who 1 year after surgery, have a normal glycated hemoglobin (HbA1c) less than 6.5% and all medication is stopped</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgery Group</title>
            <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Having Remission of Type 2 Diabetes</title>
          <description>The number of patients who 1 year after surgery, have a normal glycated hemoglobin (HbA1c) less than 6.5% and all medication is stopped</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Remission in Hypertension</title>
        <description>Percentage of participants achieving remission in hypertension, that is blood pressure less than 130/80 mm Hg without any anti-hypertensive medication</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgery Group</title>
            <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Remission in Hypertension</title>
          <description>Percentage of participants achieving remission in hypertension, that is blood pressure less than 130/80 mm Hg without any anti-hypertensive medication</description>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Surgery Group</title>
          <description>Interventional study of the effects of a novel metabolic surgery with anatomical modifications, to give remission of Type-2 Diabetes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Non-availability of hormonal tests like Glucagon-Like Peptide-1 estimation pre- &amp; post-operative.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Neeraj Gupta</name_or_title>
      <organization>Kirloskar Hospital</organization>
      <phone>+91-40-23296241</phone>
      <email>drugale@kirloskarhospital.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

